Expression of epidermal growth factor receptor, transforming growth factor-α and Ki-67 in relationship to malignant transformation of pleomorphic adenoma

Acta Oto-Laryngologica

Volumn 127, Issue 11, 2007, Pages 1207-1213

  Katori, Hideaki ^a,b   Nozawa, Akinori ^b   Tsukuda, Mamoru ^c  

^a YOKOHAMA CITY MINATO RED CROSS HOSPITAL   (Japan)

^b YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Epidermal growth factor receptor; Ki 67; Pleomorphic adenoma; Transforming growth factor

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; KI 67 ANTIGEN; TRANSFORMING GROWTH FACTOR ALPHA;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MALIGNANT TRANSFORMATION; PLEOMORPHIC ADENOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN CONTENT; PROTEIN DETERMINATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SIALOADENITIS;

ADENOMA, PLEOMORPHIC; ADULT; AGED; AGED, 80 AND OVER; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETROSPECTIVE STUDIES; SALIVARY GLAND NEOPLASMS; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR MARKERS, BIOLOGICAL;

EID: 35348985464     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.1080/00016480701230894     Document Type: Article

References (22)

1. Gnepp DR, Wenig BM. Surgical pathology of the salivary glands. Philadelphia: WB Saunders; 1991. p. 350-68.
2. Seifert G. WHO international histological classification of tumours. Histological typing of salivary gland tumours. Berlin: Springer-Verlag, 2005:122-9.
3. Gnepp DR. Malignant mixed tumors of the salivary glands. Pathol Ann 1993;28:279-328.
4. Castellini R, Vischer DW, Wykes S, Sarkar FH, Crissman JD. Interaction of transforming growth factor and epidermal growth factor receptor in breast carcinoma: an immunohistochemical study. Cancer 1994;73:344-9.
5. Wong CJW, Gallagher GJ, Gertz R, Chang AL, Shklar G. TGF-alpha in chemically transformed hamster oral keratinocytes. Cancer Res 1988;48:3130-4.
6. Grandes JR, Tweardy DJ. Elevated levels of transforming growth factor-alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res 1993;53:3579-84.
7. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984;133:1710-5.
8. Katori H, Nozawa A, Tsukuda M. Markers of malignant transformation of sinonasal inverted papilloma. Eur J Surg Oncol 2005;31:905-11.
9. Srinivasan M, Jewell SD. Evaluation of TGF-alpha and EGFR expression in oral leukoplakia and oral submucous fibrosis by quantitative immunohistochemistry. Oncology 2001;61:284-92.
10. Hall PA, Hughes CM, Staddon SL, Richman PI, Gullick WJ, Lemoine NR. The c-erbB-2 proto-oncogene in human pancreatic cancer. J Pathol 1990;161:195-200.
11. Slamon DJ, GodophinW, Jones LA, Holt JA, Wong SG, Keith DE, et al. Studies of the HER-2/neu protooncogene in human breast and ovarian cancer. Science 1989;244:707-16.
12. Ro J, El-Naggar AK, Ro JY, Blick M, Frye D, Fraschini G, et al. c-erbB-2 amplification in node negative breast cancer. Cancer Res 1989;49:6941-4.
13. Press MF, Pike MC, Hung G, Zhou JY, Ma Y, George J, et al. Amplification and overexpression of HER-2/neu in carcinomas of the salivary gland: correlation with poor prognosis. Cancer Res 1994;54:5675-82.
14. Kernohan NM, Blessing K, King G, Corbett IP, Miller ID. Expression of c-erbB-2 oncoprotein in salivary gland tumours: an immunohistochemical study. J Pathol 1991;163:77-80.
15. Sugano S, Mukai K, Tsuda H, Hirohashi S, Furuya S, Shimosato Y, et al. Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness. Laryngoscope 1992;102:923-7.
16. Karja V, Syrjanen S, Kataja V, Syrjanen K. c-erbB-2 oncogene expression in salivary gland tumours. ORL J Otorhinolaryngol Relat Spec 1994;56:206-12.
17. Shrestha P, Huang JW, Tsuji T, Shinozaki F, Maeda K, Sasaki K, et al. Rare expression of the c-erbB-2 oncoprotein in salivary gland tumours: an immunohistochemical study. J Oral Pathol Med 1992;21:477-80.
18. Booster J, De Last SW, Ponec M. Epidermal growth factor receptor expression related to differentiation capacity in normal and transformed keratinocytes. Exp Cell Res 1985;161:421-33.
19. Stoscheck CM, King LE. Role of epidermal growth factor in carcinogenesis. Cancer Res 1986;46:1030-7.
20. Cutry AF, Kinniburgh AJ, Krabak MJ, Hui SW, Wenner CE. Induction of c-fos and c-myc proto-oncogene expression by epidermal growth factor and transforming growth factor-alpha is calcium independent. J Biol Chem 1989;264:19700-75.
21. Miyaguchi M, Olfsson J, Hellquist HB. Immunohistochemical study of epidermal growth factor receptor in severe dysplasia and carcinoma in situ of vocal cords. Acta Otolaryngol (Stockh) 1991;11:149-52.
22. Filipe MI, Osborn M, Linehan J, Sanidas E, Brito MJ, Jankowski J. Expression of transforming growth factor-alpha, and epidermal growth factor receptor in precursor lesions to gastric carcinoma. Br J Cancer 1995;71:30-6.